As organizations introduce additional technologies, including AI-enabled tools and CRM platforms, these gaps become more ...

E. Almeida as Chief Executive Officer, effective immediately upon closing of the previously announced company acquisition.

Designed to expand treatment options for patients with cirrhosis and complications of portal hypertension, this ...

The FDA has approved the NEXUS Aortic Arch Stent Graft enabling commercial launch of the NEXUS System in the US.

InVera Medical has received FDA 510 (k) clearance for the InVera Infusion Device, a new minimally invasive device designed to help physicians deliver treatment more effectively to diseased leg veins, ...

Allevion Medical Receives FDA Clearance for Vantage™, Introducing a Fully Disposable Approach to Minimally Invasive Spinal ...